US20140082924A1 - Radiopaque super-elastic intravascular stent - Google Patents

Radiopaque super-elastic intravascular stent Download PDF

Info

Publication number
US20140082924A1
US20140082924A1 US14/094,310 US201314094310A US2014082924A1 US 20140082924 A1 US20140082924 A1 US 20140082924A1 US 201314094310 A US201314094310 A US 201314094310A US 2014082924 A1 US2014082924 A1 US 2014082924A1
Authority
US
United States
Prior art keywords
main body
cylindrical main
stent
inner core
cylindrical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/094,310
Inventor
Andre S. Lundkvist
David A. Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Synthes Products Inc
Original Assignee
DePuy Synthes Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DePuy Synthes Products Inc filed Critical DePuy Synthes Products Inc
Priority to US14/094,310 priority Critical patent/US20140082924A1/en
Publication of US20140082924A1 publication Critical patent/US20140082924A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B23MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23PMETAL-WORKING NOT OTHERWISE PROVIDED FOR; COMBINED OPERATIONS; UNIVERSAL MACHINE TOOLS
    • B23P13/00Making metal objects by operations essentially involving machining but not covered by a single other subclass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A61B17/12118Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526Methods of manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0076Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0039Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/4998Combined manufacture including applying or shaping of fluent material

Definitions

  • This invention relates generally to implantable vasoocclusive devices for interventional therapeutic treatment or vascular surgery, and more particularly concerns a radiopaque super-elastic intravascular stent formed from a composite wire with enhanced radiopacity and increased corrosion resistance.
  • the intravascular stent has superelastic or shape memory properties and improved radiopaque properties for visible detection under fluoroscopy, and the ends of the stent are flared radially outwardly to prevent radially and longitudinally inward deformation of the ends of the stent when the stent is stretched or disposed in a desired location in a patient's vasculature.
  • Vasoocclusive devices are therapeutic devices that are placed within the vasculature of the human body, typically via a catheter, either to block the flow of blood through a vessel making up that portion of the vasculature through the formation of an embolus or to form such an embolus within an aneurysm stemming from the vessel.
  • the vasoocclusive devices can take a variety of configurations, and are generally formed of one or more elements that are larger in the deployed configuration than when they are within the delivery catheter prior to placement.
  • One widely used vasoocclusive device is a helical wire coil having a deployed configuration that may be dimensioned to engage the walls of the vessels.
  • vasoocclusive devices which can have a primary shape of a coil of wire that is then formed into a more complex secondary shape, can be produced in such a way that they will pass through the lumen of a catheter in a linear shape and take on a complex shape as originally formed after being deployed into the area of interest, such as an aneurysm.
  • a variety of detachment mechanisms to release the device from a pusher have been developed and are known in the art.
  • microcoils formed of very small diameter wire are used in order to restrict, reinforce, or to occlude such small diameter areas of the vasculature.
  • materials have been suggested for use in such microcoils, including nickel-titanium alloys, copper, stainless steel, platinum, tungsten, various plastics or the like, each of which offers certain benefits in various applications.
  • Nickel-titanium alloys are particularly advantageous for the fabrication of such microcoils, in that they can have super-elastic or shape memory properties, and thus can be manufactured to easily fit into a linear portion of a catheter, but attain their originally formed, more complex shape when deployed.
  • nickel-titanium alloy wires are also not radiopaque in small diameters, and a single nickel-titanium wire would need to be approximately 0.012 inches in diameter to be even slightly radiopaque.
  • One known type of stent includes a metal filament material formed of a metal outer member and an inner core formed of a different metal than the outer member.
  • Another type of stent is formed of multiple filaments, each of which is a composite including a central core formed of a radiopaque and relatively ductile material such as tantalum or platinum allowing in vivo imaging of the stent, and an outer case formed of a relatively resilient material, such as a cobalt/chromium based alloy.
  • An intermediate barrier layer of tantalum, niobium or platinum may be placed between the case and core, when the core and case materials would be incompatible if contiguous, due to a tendency to form intermetallics.
  • a radiopaque case may surround the core, or to improve compatibility, a biocompatible cover layer, such as one or more of tantalum, platinum, iridium, stainless steel, niobium and titanium can surround the case.
  • Another type of endoprosthesis in the form of an elongated wire member includes a central cylindrical or tubular core and an outer tubular sheath.
  • An intermediate tubular layer may be disposed between the inner tubular layer and the outer tubular layer.
  • the tube may include outer and inner layers formed of one material such as cobalt, carbon, manganese, silicon, phosphorus, sulfur, chromium, nickel, molybdenum, titanium, iron, alloys thereof and combination thereof, and an intermediate layer between the outer and inner layers formed of another material, such as gold, platinum, tantalum, iridium, tungsten, and alloys thereof and combination thereof.
  • Another type of stent preform includes an elongated metal core of a shape-memory alloy with a solid cross section, and a hollow outer sheath made of a biocompatible polymer such as a heat-shrinkable polymer material or polymer tape to prevent the core from directly contacting the body lumen.
  • a biocompatible polymer such as a heat-shrinkable polymer material or polymer tape
  • an intermediate sleeve of a lubricious lining is disposed between the core and outer sheath.
  • stent is made from multiple knitted or braided wire strands made of materials such as stainless steel, tungsten, titanium, nickel titanium alloy, gold or silver, coated on the outside with a biocompatible fluoropolymer.
  • nickel-titanium wire such as nitinol wire has important shape memory and superelastic properties that are useful in vasoocclusive devices and stents, this material is not very radiopaque, so that it would be desirable to utilize a more radiopaque material that can be visualized under fluoroscopy. More radiopaque materials typically do not have shape memory and superelastic properties suitable for forming in vasoocclusive devices and stents, and combining such radiopaque materials with nickel-titanium wire such as nitinol wire are typically prone to galvanic corrosion, resulting in failure or compromise of the larger wire or the larger assembled system.
  • an intravascular stent formed from a structural element that offers the advantages of a shape memory alloy such as a nickel-titanium alloy, and that incorporates radiopaque material, so that the intravascular stent can be visualized under fluoroscopy, and that is not subject to galvanic corrosion during use of the device. It would also be desirable to provide an intravascular stent that will resist radially and longitudinally inward deformation of the ends of the stent when the stent is stretched or disposed in a desired location in a patient's vasculature. The present invention meets these and other needs.
  • the present invention provides for a generally tubular intravascular stent with a plurality of end loop portions at opposing first and second ends of the stent, and an intermediate tubular body portion formed of a plurality of intermediate circumferential loops between the plurality of end loop portions.
  • the intermediate tubular body portion has a first diameter, an enlarged first end and an enlarged opposing second end, and the enlarged first and second ends have a second diameter greater than the first diameter of the intermediate tubular body portion.
  • a plurality of the end loop portions flare radially outward with respect to the intermediate tubular body portion of the stent.
  • the plurality of end loop portions and the plurality of intermediate circumferential loops of the intermediate tubular body portion are formed from a single spirally wound composite wire.
  • the composite wire has a first free end and a second free end placed in close proximity to each other, and a short segment of heat shrink tubing is used to capture the first and second free ends together to prevent the free ends of the composite wire from extending away from the body of the stent.
  • the intravascular stent takes on a linear shape when stretched, without the ends shrinking to a diameter less than the diameter of the central body of the stent.
  • the composite wire may be formed as a cylindrical wire, and includes an elongated inner core having a selected length and formed from a radiopaque metal, an intermediate polymer layer coaxially disposed immediately adjacent to and surrounding the inner core, and an outer metal layer coaxially disposed immediately adjacent to and surrounding the polymer layer.
  • the radiopaque metal may be selected from the group consisting of platinum, tantalum, gold, and combinations thereof, and the inner core is typically cylindrical, although other shapes may be suitable for forming the inner core.
  • the inner core is disposed centrally along a longitudinal axis of the composite wire.
  • the polymer layer may be formed from a polymer selected from the group consisting of polytetrafluoroethylene, poly-para-xylylene, a fluorine substituted poly-para-xylylene, and combinations thereof, while the outer metal layer may be formed of a superelastic alloy, such as nitinol, for example.
  • the inner core and outer sheath may be made of dissimilar metals.
  • the present invention provides for a cylindrical mandrel including a cylindrical main body having first and second opposing ends and a longitudinal axis, a first set of four orthogonally arranged pegs extending from the cylindrical main body at the first end of the cylindrical main body, and a second set of four orthogonally arranged pegs extending from the cylindrical main body at the second end of the cylindrical main body.
  • a first conical end cap is mounted to the first end of the cylindrical main body, and a second conical end cap mounted to the second end of the cylindrical main body.
  • first and second conical end caps have conically tapered surfaces forming a tapered angle at the first and second ends of the cylindrical main body, and in another aspect the tapered angle is about 30° with respect to the longitudinal axis of the cylindrical main body.
  • the invention provides for a method for forming an intravascular stent, including the steps of winding a single composite wire about a first peg of the first set of pegs of the mandrel at the first end of the mandrel to form a first end loop portion at the first end of the stent, and thereafter transitioning to form an intermediate circumferential loop; winding the composite wire about a first peg of the second set of pegs at the second end of the cylindrical mandrel to form a first end loop portion at the second end of the stent, and thereafter transitioning to form an intermediate circumferential loop; and repeating these steps to continue sequentially to form a plurality of intermediate circumferential loops between a plurality of end loop portions at the opposing first and second ends of the mandrel.
  • FIG. 1 is a perspective view of a selected length of a composite wire according to the present invention.
  • FIG. 2 is a cross sectional view of the composite wire taken along line 2 - 2 of FIG. 1 .
  • FIG. 3 is a top plan view of a radiopaque super-elastic intravascular stent formed from a composite wire according to the present invention.
  • FIG. 4 is a side elevational view of the radiopaque super-elastic intravascular stent of FIG. 3 .
  • FIG. 5 is an end view of the radiopaque super-elastic intravascular stent of FIG. 3 .
  • FIG. 6 is a side elevational view of a mandrel for winding the radiopaque super-elastic intravascular stent of FIG. 3 .
  • the invention is embodied in a radiopaque super-elastic intravascular stent 8 , illustrated in FIGS. 3-6 , formed from a composite wire for forming a vascular interventional device, such as intravascular stents, embolization coils and guidewires, for example.
  • the composite wire 10 includes an elongated inner core 12 having a selected length and formed from a radiopaque metal, such as, but not limited to, platinum, tantalum, gold, or combinations thereof, for example.
  • the inner core is preferably cylindrical in configuration although other shapes may be used in forming the core, and the inner core is preferably disposed centrally along a longitudinal axis 14 of the composite wire, although alternatively the inner core may be displaced from the central longitudinal axis of the composite wire.
  • intermediate polymer layer 16 Located adjacent to and surrounding the inner core is an intermediate polymer layer 16 that is preferably coaxially disposed about the inner core.
  • the intermediate polymer layer is formed by a thin continuous polymeric layer of material such as, but not limited to, polytetrafluoroethylene (PTFE), poly-para-xylylene (parylene), or its high temperature resistant derivatives, such as a fluorine substituted poly-para-xylylene (parylene HT), for example, or combinations thereof.
  • PTFE polytetrafluoroethylene
  • parylene poly-para-xylylene
  • parylene HT fluorine substituted poly-para-xylylene
  • an outer metal layer 18 Located adjacent to and surrounding the intermediate polymer layer is an outer metal layer 18 that is preferably coaxially disposed about the intermediate polymer layer.
  • the inner core and the outer metal layer are made of dissimilar metals, and the outer metal layer is formed of a superelastic alloy, such as nitinol, for example, although other metallic materials may be used for forming the outer metal layer.
  • the intermediate polymer layer advantageously insulates the metallic core and outer metal layer from galvanic corrosion.
  • the intravascular stent is formed in a generally tubular shape having an intermediate tubular body portion 20 having a first diameter D 1 , an enlarged first end 22 and an enlarged opposing second end 24 .
  • the enlarged first and second ends preferably have a second diameter D 2 greater than the first diameter of the intermediate tubular body portion.
  • the intravascular stent is currently preferably formed from a single composite wire spirally wound to form a plurality of intermediate circumferential loops 26 between a plurality of end loop portions 28 at the opposing first and second ends of the stent.
  • a plurality of the end loop portions 30 a , 30 b , 30 c , 30 d flare radially outward with respect to the intermediate tubular body portion of the stent.
  • the flared intravascular stent typically takes on a linear shape when stretched, without the ends shrinking to a diameter less than the diameter of the central body of the stent.
  • the composite wire that forms the intravascular stent has a first free end 32 and a second free end 34 that are placed in close proximity to each other, and are captured together within a short segment of heat shrink tubing 36 to prevent the free ends of the composite wire from extending away from the body of the stent.
  • the intravascular stent is formed by winding a length of the single composite wire spirally about a cylindrical mandrel 40 having a first set 42 of four orthogonally arranged pegs 44 a , 44 b , 44 c , 44 d (hidden) extending from the mandrel at the first end 46 of the mandrel, and a second set 48 of four orthogonally arranged pegs 50 a , 50 b , 50 c , 50 d (hidden) extending from the mandrel at the second end 52 of the mandrel.
  • a first conical end cap 54 and a second conical end cap 56 are mounted to the first and second ends of the mandrel.
  • the first and second conical end caps have conically tapered surfaces 58 , 60 forming an angle ⁇ typically of about 30° with respect to the longitudinal axis 62 of the mandrel at the first and second ends of the mandrel, to provide radially outwardly flaring surfaces for shaping the outwardly flaring end loops of the intravascular stent.
  • a single composite wire is wound about a first peg 44 b of the first set of pegs at the first end of the mandrel to form a first end loop portion 64 at the first end of the stent, thereafter transitioning to form an intermediate circumferential loop 66 .
  • the composite wire is then wound about a first peg 50 c of the second set of pegs at the second end of the mandrel to form a first end loop portion (hidden) at the second end of the stent, thereafter transitioning to form another intermediate circumferential loop, and so on, continuing sequentially in this manner thereafter to form the plurality of intermediate circumferential loops between a plurality of end loop portions at the opposing first and second ends of the stent.
  • the winding may begin at any stage, such as by first winding about the cylindrical mandrel to form an intermediate circumferential loop, followed by winding about a peg at an end of the mandrel to form an end loop portion, and so on sequentially in this manner.
  • the radiopaque super-elastic intravascular stent of the present invention is designed to be deployed intravascularly without the necessity of balloons or other expansive elements, and can be deployed from a guiding catheter directly into the area to be treated.
  • the intravascular device of the present invention is particularly useful for treatment of damaged arteries incorporating aneurysms and the like, particularly those which are treatable by the use of embolic coils or other embolic devices or agents used to occlude the aneurysm.
  • the intravascular stent of the invention is particularly well adapted to use with the types of catheters used to place such embolic coils in aneurysms, and the device may be used to reinforce the area in the vicinity of an aneurysm while allowing placement of one or more embolic coils through the gaps in the stent, and while assisting in the retention of the embolic devices within a dome of the aneurysm.

Abstract

The intravascular stent is formed from a composite wire includes an inner core of radiopaque metal, a polymer layer coaxially disposed about the inner core, and an outer metal layer coaxially disposed about the polymer layer. The intermediary polymer layer acts as a barrier material between the inner core and the outer sheath, so that the inner core and outer sheath may be made of dissimilar metallic layers, and the intermediary polymer layer will prevent a galvanic reaction between the inner core and the peripheral metal layer. The intravascular stent has ends flared radially outwardly to prevent radially and longitudinally inward deformation of the ends of the stent when the stent is disposed in a desired location in a patient's vasculature.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS INVENTION
  • This application is a divisional of U.S. Ser. No. 11/970,338, filed on Jan. 7, 2008, which is incorporated by reference in its entirety.
  • BACKGROUND OF THE INVENTION
  • This invention relates generally to implantable vasoocclusive devices for interventional therapeutic treatment or vascular surgery, and more particularly concerns a radiopaque super-elastic intravascular stent formed from a composite wire with enhanced radiopacity and increased corrosion resistance. The intravascular stent has superelastic or shape memory properties and improved radiopaque properties for visible detection under fluoroscopy, and the ends of the stent are flared radially outwardly to prevent radially and longitudinally inward deformation of the ends of the stent when the stent is stretched or disposed in a desired location in a patient's vasculature.
  • Vasoocclusive devices are therapeutic devices that are placed within the vasculature of the human body, typically via a catheter, either to block the flow of blood through a vessel making up that portion of the vasculature through the formation of an embolus or to form such an embolus within an aneurysm stemming from the vessel. The vasoocclusive devices can take a variety of configurations, and are generally formed of one or more elements that are larger in the deployed configuration than when they are within the delivery catheter prior to placement. One widely used vasoocclusive device is a helical wire coil having a deployed configuration that may be dimensioned to engage the walls of the vessels.
  • The vasoocclusive devices, which can have a primary shape of a coil of wire that is then formed into a more complex secondary shape, can be produced in such a way that they will pass through the lumen of a catheter in a linear shape and take on a complex shape as originally formed after being deployed into the area of interest, such as an aneurysm. A variety of detachment mechanisms to release the device from a pusher have been developed and are known in the art.
  • For treatment of areas of the small diameter vasculature such as a small artery or vein in the brain, for example, and for treatment of aneurysms and the like, microcoils formed of very small diameter wire are used in order to restrict, reinforce, or to occlude such small diameter areas of the vasculature. A variety of materials have been suggested for use in such microcoils, including nickel-titanium alloys, copper, stainless steel, platinum, tungsten, various plastics or the like, each of which offers certain benefits in various applications. Nickel-titanium alloys are particularly advantageous for the fabrication of such microcoils, in that they can have super-elastic or shape memory properties, and thus can be manufactured to easily fit into a linear portion of a catheter, but attain their originally formed, more complex shape when deployed. However, nickel-titanium alloy wires are also not radiopaque in small diameters, and a single nickel-titanium wire would need to be approximately 0.012 inches in diameter to be even slightly radiopaque. However, such a thickness of a single nickel-titanium wire would unfortunately also be relatively stiff and possibly traumatic to the placement site, particularly if used for treatment of delicate and already damaged areas of the small diameter vasculature such as an aneurysm in an artery or vein in the brain, for example.
  • One known type of stent includes a metal filament material formed of a metal outer member and an inner core formed of a different metal than the outer member. Another type of stent is formed of multiple filaments, each of which is a composite including a central core formed of a radiopaque and relatively ductile material such as tantalum or platinum allowing in vivo imaging of the stent, and an outer case formed of a relatively resilient material, such as a cobalt/chromium based alloy. An intermediate barrier layer of tantalum, niobium or platinum may be placed between the case and core, when the core and case materials would be incompatible if contiguous, due to a tendency to form intermetallics. A radiopaque case may surround the core, or to improve compatibility, a biocompatible cover layer, such as one or more of tantalum, platinum, iridium, stainless steel, niobium and titanium can surround the case.
  • Another type of endoprosthesis in the form of an elongated wire member is known that includes a central cylindrical or tubular core and an outer tubular sheath. An intermediate tubular layer may be disposed between the inner tubular layer and the outer tubular layer. The tube may include outer and inner layers formed of one material such as cobalt, carbon, manganese, silicon, phosphorus, sulfur, chromium, nickel, molybdenum, titanium, iron, alloys thereof and combination thereof, and an intermediate layer between the outer and inner layers formed of another material, such as gold, platinum, tantalum, iridium, tungsten, and alloys thereof and combination thereof.
  • Another type of stent preform includes an elongated metal core of a shape-memory alloy with a solid cross section, and a hollow outer sheath made of a biocompatible polymer such as a heat-shrinkable polymer material or polymer tape to prevent the core from directly contacting the body lumen. In another type of stent perform, an intermediate sleeve of a lubricious lining is disposed between the core and outer sheath.
  • Another type of stent is known that is made from multiple knitted or braided wire strands made of materials such as stainless steel, tungsten, titanium, nickel titanium alloy, gold or silver, coated on the outside with a biocompatible fluoropolymer.
  • While nickel-titanium wire such as nitinol wire has important shape memory and superelastic properties that are useful in vasoocclusive devices and stents, this material is not very radiopaque, so that it would be desirable to utilize a more radiopaque material that can be visualized under fluoroscopy. More radiopaque materials typically do not have shape memory and superelastic properties suitable for forming in vasoocclusive devices and stents, and combining such radiopaque materials with nickel-titanium wire such as nitinol wire are typically prone to galvanic corrosion, resulting in failure or compromise of the larger wire or the larger assembled system. It has also been found that when an intravascular stent is stretched longitudinally, the stent will naturally shrink in diameter, but will not shrink uniformly, in that the ends of the stent will commonly shrink in diameter to a greater extent than the diameter of a central body portion of the stent shrinks, resulting in a condition referred to as “fishmouthing” of the stent.
  • It would thus be desirable to provide an intravascular stent formed from a structural element that offers the advantages of a shape memory alloy such as a nickel-titanium alloy, and that incorporates radiopaque material, so that the intravascular stent can be visualized under fluoroscopy, and that is not subject to galvanic corrosion during use of the device. It would also be desirable to provide an intravascular stent that will resist radially and longitudinally inward deformation of the ends of the stent when the stent is stretched or disposed in a desired location in a patient's vasculature. The present invention meets these and other needs.
  • SUMMARY OF THE INVENTION
  • Briefly, and in general terms, the present invention provides for a generally tubular intravascular stent with a plurality of end loop portions at opposing first and second ends of the stent, and an intermediate tubular body portion formed of a plurality of intermediate circumferential loops between the plurality of end loop portions. The intermediate tubular body portion has a first diameter, an enlarged first end and an enlarged opposing second end, and the enlarged first and second ends have a second diameter greater than the first diameter of the intermediate tubular body portion. In a presently preferred aspect, a plurality of the end loop portions flare radially outward with respect to the intermediate tubular body portion of the stent. In another preferred aspect, the plurality of end loop portions and the plurality of intermediate circumferential loops of the intermediate tubular body portion are formed from a single spirally wound composite wire. The composite wire has a first free end and a second free end placed in close proximity to each other, and a short segment of heat shrink tubing is used to capture the first and second free ends together to prevent the free ends of the composite wire from extending away from the body of the stent. The intravascular stent takes on a linear shape when stretched, without the ends shrinking to a diameter less than the diameter of the central body of the stent.
  • In another presently preferred aspect, the composite wire may be formed as a cylindrical wire, and includes an elongated inner core having a selected length and formed from a radiopaque metal, an intermediate polymer layer coaxially disposed immediately adjacent to and surrounding the inner core, and an outer metal layer coaxially disposed immediately adjacent to and surrounding the polymer layer. The radiopaque metal may be selected from the group consisting of platinum, tantalum, gold, and combinations thereof, and the inner core is typically cylindrical, although other shapes may be suitable for forming the inner core. In a preferred aspect, the inner core is disposed centrally along a longitudinal axis of the composite wire.
  • In another preferred aspect, the polymer layer may be formed from a polymer selected from the group consisting of polytetrafluoroethylene, poly-para-xylylene, a fluorine substituted poly-para-xylylene, and combinations thereof, while the outer metal layer may be formed of a superelastic alloy, such as nitinol, for example. In another aspect, the inner core and outer sheath may be made of dissimilar metals.
  • In another aspect, the present invention provides for a cylindrical mandrel including a cylindrical main body having first and second opposing ends and a longitudinal axis, a first set of four orthogonally arranged pegs extending from the cylindrical main body at the first end of the cylindrical main body, and a second set of four orthogonally arranged pegs extending from the cylindrical main body at the second end of the cylindrical main body. A first conical end cap is mounted to the first end of the cylindrical main body, and a second conical end cap mounted to the second end of the cylindrical main body. In a presently preferred aspect, the first and second conical end caps have conically tapered surfaces forming a tapered angle at the first and second ends of the cylindrical main body, and in another aspect the tapered angle is about 30° with respect to the longitudinal axis of the cylindrical main body.
  • In another presently preferred aspect, the invention provides for a method for forming an intravascular stent, including the steps of winding a single composite wire about a first peg of the first set of pegs of the mandrel at the first end of the mandrel to form a first end loop portion at the first end of the stent, and thereafter transitioning to form an intermediate circumferential loop; winding the composite wire about a first peg of the second set of pegs at the second end of the cylindrical mandrel to form a first end loop portion at the second end of the stent, and thereafter transitioning to form an intermediate circumferential loop; and repeating these steps to continue sequentially to form a plurality of intermediate circumferential loops between a plurality of end loop portions at the opposing first and second ends of the mandrel.
  • These and other aspects and advantages of the invention will become apparent from the following detailed description and the accompanying drawings, which illustrate by way of example the features of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a selected length of a composite wire according to the present invention.
  • FIG. 2 is a cross sectional view of the composite wire taken along line 2-2 of FIG. 1.
  • FIG. 3 is a top plan view of a radiopaque super-elastic intravascular stent formed from a composite wire according to the present invention.
  • FIG. 4 is a side elevational view of the radiopaque super-elastic intravascular stent of FIG. 3.
  • FIG. 5 is an end view of the radiopaque super-elastic intravascular stent of FIG. 3.
  • FIG. 6 is a side elevational view of a mandrel for winding the radiopaque super-elastic intravascular stent of FIG. 3.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • As is illustrated in the drawings, which are provided for the purposes of illustration and not by way of limitation, the invention is embodied in a radiopaque super-elastic intravascular stent 8, illustrated in FIGS. 3-6, formed from a composite wire for forming a vascular interventional device, such as intravascular stents, embolization coils and guidewires, for example. Referring to FIGS. 1 and 2, the composite wire 10 includes an elongated inner core 12 having a selected length and formed from a radiopaque metal, such as, but not limited to, platinum, tantalum, gold, or combinations thereof, for example. The inner core is preferably cylindrical in configuration although other shapes may be used in forming the core, and the inner core is preferably disposed centrally along a longitudinal axis 14 of the composite wire, although alternatively the inner core may be displaced from the central longitudinal axis of the composite wire.
  • Immediately adjacent to and surrounding the inner core is an intermediate polymer layer 16 that is preferably coaxially disposed about the inner core. The intermediate polymer layer is formed by a thin continuous polymeric layer of material such as, but not limited to, polytetrafluoroethylene (PTFE), poly-para-xylylene (parylene), or its high temperature resistant derivatives, such as a fluorine substituted poly-para-xylylene (parylene HT), for example, or combinations thereof.
  • Immediately adjacent to and surrounding the intermediate polymer layer is an outer metal layer 18 that is preferably coaxially disposed about the intermediate polymer layer. In a presently preferred aspect, the inner core and the outer metal layer are made of dissimilar metals, and the outer metal layer is formed of a superelastic alloy, such as nitinol, for example, although other metallic materials may be used for forming the outer metal layer. The intermediate polymer layer advantageously insulates the metallic core and outer metal layer from galvanic corrosion.
  • Referring to FIGS. 3-5, the intravascular stent is formed in a generally tubular shape having an intermediate tubular body portion 20 having a first diameter D1, an enlarged first end 22 and an enlarged opposing second end 24. The enlarged first and second ends preferably have a second diameter D2 greater than the first diameter of the intermediate tubular body portion. The intravascular stent is currently preferably formed from a single composite wire spirally wound to form a plurality of intermediate circumferential loops 26 between a plurality of end loop portions 28 at the opposing first and second ends of the stent. In another presently preferred aspect, a plurality of the end loop portions 30 a, 30 b, 30 c, 30 d flare radially outward with respect to the intermediate tubular body portion of the stent. The flared intravascular stent typically takes on a linear shape when stretched, without the ends shrinking to a diameter less than the diameter of the central body of the stent.
  • With reference to FIG. 4, the composite wire that forms the intravascular stent has a first free end 32 and a second free end 34 that are placed in close proximity to each other, and are captured together within a short segment of heat shrink tubing 36 to prevent the free ends of the composite wire from extending away from the body of the stent.
  • As is illustrated in FIG. 6, the intravascular stent is formed by winding a length of the single composite wire spirally about a cylindrical mandrel 40 having a first set 42 of four orthogonally arranged pegs 44 a, 44 b, 44 c, 44 d (hidden) extending from the mandrel at the first end 46 of the mandrel, and a second set 48 of four orthogonally arranged pegs 50 a, 50 b, 50 c, 50 d (hidden) extending from the mandrel at the second end 52 of the mandrel. A first conical end cap 54 and a second conical end cap 56 are mounted to the first and second ends of the mandrel. The first and second conical end caps have conically tapered surfaces 58, 60 forming an angle α typically of about 30° with respect to the longitudinal axis 62 of the mandrel at the first and second ends of the mandrel, to provide radially outwardly flaring surfaces for shaping the outwardly flaring end loops of the intravascular stent.
  • According to the method of the invention, a single composite wire is wound about a first peg 44 b of the first set of pegs at the first end of the mandrel to form a first end loop portion 64 at the first end of the stent, thereafter transitioning to form an intermediate circumferential loop 66. The composite wire is then wound about a first peg 50 c of the second set of pegs at the second end of the mandrel to form a first end loop portion (hidden) at the second end of the stent, thereafter transitioning to form another intermediate circumferential loop, and so on, continuing sequentially in this manner thereafter to form the plurality of intermediate circumferential loops between a plurality of end loop portions at the opposing first and second ends of the stent. As will be readily apparent, the winding may begin at any stage, such as by first winding about the cylindrical mandrel to form an intermediate circumferential loop, followed by winding about a peg at an end of the mandrel to form an end loop portion, and so on sequentially in this manner.
  • The radiopaque super-elastic intravascular stent of the present invention is designed to be deployed intravascularly without the necessity of balloons or other expansive elements, and can be deployed from a guiding catheter directly into the area to be treated. The intravascular device of the present invention is particularly useful for treatment of damaged arteries incorporating aneurysms and the like, particularly those which are treatable by the use of embolic coils or other embolic devices or agents used to occlude the aneurysm. More particularly, the intravascular stent of the invention is particularly well adapted to use with the types of catheters used to place such embolic coils in aneurysms, and the device may be used to reinforce the area in the vicinity of an aneurysm while allowing placement of one or more embolic coils through the gaps in the stent, and while assisting in the retention of the embolic devices within a dome of the aneurysm.
  • It will be apparent from the foregoing that while particular forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.

Claims (13)

1. A cylindrical mandrel, comprising:
a cylindrical main body having first and second opposing ends and a longitudinal axis;
a first set of four orthogonally arranged pegs extending from the cylindrical main body at the first end of the cylindrical main body;
a second set of four orthogonally arranged pegs extending from the cylindrical main body at the second end of the cylindrical main body;
a first conical end cap mounted to said first end of said cylindrical main body; and
a second conical end cap mounted to the second end of the cylindrical main body.
2. The mandrel of claim 1, wherein said first and second conical end caps have conically tapered surfaces forming a tapered angle at the first and second ends of the cylindrical main body.
3. The mandrel of claim 2, wherein said tapered angle is about 30° with respect to the longitudinal axis of the cylindrical main body.
4. A method for forming an intravascular stent, comprising:
a) providing a cylindrical mandrel including a cylindrical main body having first and second opposing ends and a longitudinal axis, a first set of four orthogonally arranged pegs extending from the cylindrical main body at the first end of the cylindrical main body, a second set of four orthogonally arranged pegs extending from the cylindrical main body at the second end of the cylindrical main body, a first conical end cap mounted to said first end of said cylindrical main body, and a second conical end cap mounted to the second end of the cylindrical main body;
b) winding a single composite wire about a first peg of the first set of pegs at the first end of the cylindrical mandrel to form a first end loop portion at a first end of a stent, and thereafter transitioning to form an intermediate circumferential loop;
c) winding the composite wire about a first peg of the second set of pegs at the second end of the cylindrical mandrel to form a first end loop portion at a second end of the stent, and thereafter transitioning to form an intermediate circumferential loop; and
d) repeating steps b) and c) alternatingly, beginning with one of steps b) and c), to continue sequentially to form a plurality of intermediate circumferential loops between a plurality of end loop portions at the first and second ends of the cylindrical mandrel.
5. The method of claim 4, wherein said plurality of intermediate circumferential loops between said plurality of end loop portions form an intermediate tubular body portion, said intermediate tubular body portion having a first diameter, an enlarged first end and an enlarged opposing second end, and said enlarged first and second ends having a second diameter greater than the first diameter of the intermediate tubular body portion.
6. The method of claim 4, wherein said single composite wire comprises a spirally wound composite wire including an elongated inner core having a selected length and an outer metal layer coaxially disposed around said elongated inner core along the length of said elongated inner core.
7. The method of claim 6, wherein said elongated inner core and said outer metal layer are made of dissimilar metals, and a continuous intermediate polymer layer is disposed between said outer metal layer and said elongated inner core, said continuous intermediate polymer layer being configured to prevent current flow between said elongated inner core and said outer metal layer.
8. The method of claim 4, wherein said intravascular stent takes on a linear shape when stretched, without the ends shrinking to a diameter less than the diameter of the central body of the stent when disposed in a desired location in a patient's vasculature.
9. The method of claim 5, wherein a plurality of said end loop portions flare radially outward with respect to the intermediate tubular body portion of the stent.
10. The method of claim 7, wherein said continuous intermediate polymer layer is formed from a polymer selected from the group consisting of polytetrafluoroethylene, poly-para-xylylene, a fluorine substituted poly-para-xylylene, and combinations thereof.
11. The method of claim 7, wherein said outer metal layer is formed of a superelastic alloy.
12. The method of claim 7, wherein said outer metal layer is formed of nitinol.
13. The method of claim 7, wherein said composite wire is formed as a cylindrical wire.
US14/094,310 2008-01-07 2013-12-02 Radiopaque super-elastic intravascular stent Abandoned US20140082924A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/094,310 US20140082924A1 (en) 2008-01-07 2013-12-02 Radiopaque super-elastic intravascular stent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/970,338 US8623071B2 (en) 2008-01-07 2008-01-07 Radiopaque super-elastic intravascular stent
US14/094,310 US20140082924A1 (en) 2008-01-07 2013-12-02 Radiopaque super-elastic intravascular stent

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/970,338 Division US8623071B2 (en) 2008-01-07 2008-01-07 Radiopaque super-elastic intravascular stent

Publications (1)

Publication Number Publication Date
US20140082924A1 true US20140082924A1 (en) 2014-03-27

Family

ID=40589799

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/970,338 Expired - Fee Related US8623071B2 (en) 2008-01-07 2008-01-07 Radiopaque super-elastic intravascular stent
US12/709,734 Expired - Fee Related US8597344B2 (en) 2008-01-07 2010-02-22 Radiopaque super-elastic intravascular stent
US14/068,691 Abandoned US20140058500A1 (en) 2008-01-07 2013-10-31 Radiopaque super-elastic intravascular stent
US14/094,310 Abandoned US20140082924A1 (en) 2008-01-07 2013-12-02 Radiopaque super-elastic intravascular stent

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US11/970,338 Expired - Fee Related US8623071B2 (en) 2008-01-07 2008-01-07 Radiopaque super-elastic intravascular stent
US12/709,734 Expired - Fee Related US8597344B2 (en) 2008-01-07 2010-02-22 Radiopaque super-elastic intravascular stent
US14/068,691 Abandoned US20140058500A1 (en) 2008-01-07 2013-10-31 Radiopaque super-elastic intravascular stent

Country Status (7)

Country Link
US (4) US8623071B2 (en)
EP (1) EP2247268B1 (en)
JP (1) JP5419893B2 (en)
CN (1) CN101969891B (en)
CA (2) CA2711484C (en)
ES (1) ES2585404T3 (en)
WO (2) WO2009089216A2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
DE102015107291B4 (en) * 2014-05-28 2017-06-08 Acandis Gmbh & Co. Kg stent
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10806560B2 (en) 2015-05-18 2020-10-20 Pulmair Medical, Inc. Implantable artificial bronchus and use of an implantable artificial bronchus
USD902407S1 (en) 2019-11-19 2020-11-17 Pulmair Medical, Inc. Implantable artificial bronchus
USD954953S1 (en) 2020-11-03 2022-06-14 Pulmair Medical, Inc. Implantable artificial bronchus
USD1014758S1 (en) 2023-04-19 2024-02-13 Pulmair Medical, Inc. Implantable artificial bronchus

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
EP1769774A1 (en) * 2005-10-03 2007-04-04 Noureddine Frid Radiopaque endoprostheses
CN103767810B (en) 2006-10-22 2016-06-15 Idev科技公司 From the manufacturing process of extendable bracket
JP4943827B2 (en) * 2006-11-30 2012-05-30 矢崎総業株式会社 Resistance welding method and conductor unit
JP5734650B2 (en) 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド Self-expanding prosthesis
US9034007B2 (en) * 2007-09-21 2015-05-19 Insera Therapeutics, Inc. Distal embolic protection devices with a variable thickness microguidewire and methods for their use
US8623071B2 (en) * 2008-01-07 2014-01-07 DePuy Synthes Products, LLC Radiopaque super-elastic intravascular stent
US8151682B2 (en) 2009-01-26 2012-04-10 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
JP6082351B2 (en) * 2010-12-13 2017-02-15 マイクロベンション インコーポレイテッド Stent
US9867725B2 (en) 2010-12-13 2018-01-16 Microvention, Inc. Stent
DE102011011150B4 (en) * 2011-02-14 2012-10-18 Acandis Gmbh & Co. Kg Medical device with an expandable mesh
AU2012203620B9 (en) * 2011-06-24 2014-10-02 Cook Medical Technologies Llc Helical Stent
CN102429750B (en) 2011-08-15 2015-05-20 上海微创医疗器械(集团)有限公司 Intravascular stent with improved developing performance and method for improving developing performance of intravascular stent
FR2984724B1 (en) * 2011-12-23 2014-01-24 Assist Publ Hopitaux De Paris EXPANSIVE PROSTHESIS INTENDED TO BE IMPLANTED IN THE DIGESTIVE TUBE OF A PATIENT.
US9119736B2 (en) 2012-01-27 2015-09-01 Medtronic Vascular, Inc. Hollow drug-filled stent and method of forming hollow drug-filled stent
US9345596B2 (en) * 2012-02-23 2016-05-24 Medtronic Vascular, Inc. Method of forming a nitinol stent
CN102626528A (en) * 2012-04-16 2012-08-08 上海交通大学 Gradually-expanding intravascular stent
CN102697587A (en) * 2012-06-25 2012-10-03 吕文峰 Biodegradable bracket and preparation method thereof
AU2014214841B2 (en) * 2013-02-08 2018-02-22 Endoshape, Inc. Radiopaque polymers for medical devices
US8715315B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment systems
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
WO2014150288A2 (en) 2013-03-15 2014-09-25 Insera Therapeutics, Inc. Vascular treatment devices and methods
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
KR101498584B1 (en) * 2013-05-15 2015-03-04 주식회사 스텐다드싸이텍 Stent to prevent migration
US9846308B2 (en) 2014-01-24 2017-12-19 Osterhout Group, Inc. Haptic systems for head-worn computers
US20150305826A1 (en) * 2014-04-29 2015-10-29 Stryker Corporation Method for producing radiopaque medical implants
CA2961664C (en) * 2014-10-09 2020-04-14 Boston Scientific Scimed, Inc. Pancreatic stent with drainage feature
WO2016115173A1 (en) * 2015-01-12 2016-07-21 Microvention, Inc. Stent
DE202015102114U1 (en) 2015-04-28 2015-05-21 Acandis Gmbh & Co. Kg Stent and stent delivery system
DE202015105466U1 (en) * 2015-10-15 2015-11-09 Acandis Gmbh & Co. Kg stent
US10004617B2 (en) * 2015-10-20 2018-06-26 Cook Medical Technologies Llc Woven stent device and manufacturing method
DE102016102503A1 (en) * 2016-02-12 2017-08-17 Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) Method of making a stent and stent
JP2019508201A (en) 2016-02-16 2019-03-28 インセラ セラピューティクス,インク. Suction device and fixed blood flow bypass device
US10470904B2 (en) 2016-05-18 2019-11-12 Boston Scientific Scimed, Inc. Stent retrieval system
EP3295969A1 (en) * 2016-09-20 2018-03-21 Cook Medical Technologies LLC Radiopaque composite wire for medical applications and method of making a radiopaque composite wire
US11076514B1 (en) 2016-10-04 2021-07-27 Triton Systems, Inc. Metalized fiber mat
WO2018089697A1 (en) * 2016-11-10 2018-05-17 Medtronic Vascular Inc. Stents formed from dissimilar metals for tissue growth control
CN106937894A (en) * 2017-03-16 2017-07-11 贵州医科大学附属医院 Strengthen development mark, intravascular stent and the method for intravascular stent developing performance
US11724075B2 (en) * 2017-04-18 2023-08-15 W. L. Gore & Associates, Inc. Deployment constraining sheath that enables staged deployment by device section
US10238466B2 (en) * 2017-06-15 2019-03-26 Cook Medical Technologies Llc Method of making a superelastic medical device with a radiopaque marker
CN114712044A (en) * 2017-07-27 2022-07-08 波士顿科学国际有限公司 Adjustable mandrel for forming stents with anti-migration features
EP3446661B1 (en) * 2017-08-21 2021-12-29 Cook Medical Technologies LLC Braided stent crown geometry and flare
CN210056359U (en) 2017-10-20 2020-02-14 阿坎迪斯有限公司 Support frame
JP6989698B2 (en) 2017-10-25 2022-01-05 ボストン サイエンティフィック サイムド, インコーポレイテッドBoston Scientific Scimed, Inc. Stent with non-traumatic spacer
WO2019089741A1 (en) 2017-11-01 2019-05-09 Boston Scientific Scimed, Inc. Esophageal stent including a valve member
US11065009B2 (en) * 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
US11065136B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
CN108295316B (en) * 2018-03-08 2021-03-26 戴庆涛 Intestinal tract stent and manufacturing method thereof
CN109893311B (en) * 2018-12-07 2023-06-30 上海百心安生物技术股份有限公司 Degradable bracket and manufacturing method thereof
DE102018133285B4 (en) 2018-12-21 2020-07-02 Acandis Gmbh Medical device, in particular stent, and set with such a device
DE102019104828B4 (en) * 2019-02-26 2021-12-16 Acandis Gmbh Medical device, in particular flow diverter, and set with such a device
US11406403B2 (en) 2019-06-14 2022-08-09 Neuravi Limited Visibility of mechanical thrombectomy device during diagnostic imaging
USD1001267S1 (en) * 2020-07-13 2023-10-10 Saliva Management Systems, Inc. Saliva management system
CN113288314A (en) * 2021-01-06 2021-08-24 微创神通医疗科技(上海)有限公司 Vascular implant and medical equipment

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5685933A (en) * 1993-04-26 1997-11-11 Toyota Jidosha Kabushiki Kaisha Method of manufacturing a drive shaft
US5858556A (en) * 1997-01-21 1999-01-12 Uti Corporation Multilayer composite tubular structure and method of making
US6217609B1 (en) * 1998-06-30 2001-04-17 Schneider (Usa) Inc Implantable endoprosthesis with patterned terminated ends and methods for making same
US20030212450A1 (en) * 2002-05-11 2003-11-13 Tilman Schlick Stent
WO2004047681A1 (en) * 2002-11-20 2004-06-10 Younes Boudjemline Method for making a medical implant with open-work structure and implant obtained by said method
US7101392B2 (en) * 1992-03-31 2006-09-05 Boston Scientific Corporation Tubular medical endoprostheses
US7125464B2 (en) * 2001-12-20 2006-10-24 Boston Scientific Santa Rosa Corp. Method for manufacturing an endovascular graft section
US20090177268A1 (en) * 2008-01-07 2009-07-09 Micrus Endovascular Corporation Radiopaque super-elastic intravascular stent
US20100191319A1 (en) * 2009-01-26 2010-07-29 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
US8052744B2 (en) * 2006-09-15 2011-11-08 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US20130289704A1 (en) * 2012-04-26 2013-10-31 Medtronic Vascular, Inc. Radiopaque Enhanced Cobalt Alloy for Stents
US20130289705A1 (en) * 2012-04-26 2013-10-31 Medtronic Vascular, Inc. Radiopaque Enhanced Nickel Alloy for Stents

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2841546A (en) * 1952-12-03 1958-07-01 Dow Chemical Co Extruded magnesium anodes with aluminum-coated steel core wires
US3306088A (en) * 1965-10-07 1967-02-28 Nat Standard Co Method of making an aluminum clad steel wire
US3465429A (en) * 1966-01-27 1969-09-09 Imp Metal Ind Kynoch Ltd Superconductors
US3509617A (en) * 1968-02-28 1970-05-05 Olin Mathieson Cylindrical or rod-like composite article
US3841127A (en) * 1970-11-23 1974-10-15 Dow Chemical Co Method of extruding consumable anodes with anodized core-cladding interface
US3742588A (en) * 1971-05-06 1973-07-03 Dow Chemical Co Consumable magnesium anode with a tin-coated, ferrous metal core wire
US3874066A (en) * 1972-04-11 1975-04-01 Garphytte Bruk Ab Preparation of compound wire
NL7405741A (en) * 1973-06-22 1974-12-24
USRE32399E (en) * 1977-04-30 1987-04-14 Hitachi Cable, Ltd. Method for the manufacture of a composite metal wire
DE2837847C2 (en) * 1977-08-31 1985-04-25 Hitachi, Ltd., Tokio/Tokyo Coating press for making clad wires
US4224085A (en) * 1978-07-21 1980-09-23 The International Nickel Co., Inc. Wire forming process
US4270373A (en) * 1979-05-30 1981-06-02 Motoshiro Hirato Apparatus and process for the fluid lubrication drawing of composite metal wires
US4865933A (en) * 1984-08-22 1989-09-12 Blanyer Richard J Battery grid structure made of composite wire
US4686153A (en) * 1984-12-08 1987-08-11 Fujikura Ltd. Electrode wire for use in electric discharge machining and process for preparing same
US4659310A (en) * 1985-01-22 1987-04-21 Kottemann William J Orthodontic archwire
JPS62148121A (en) * 1985-12-20 1987-07-02 Sumitomo Electric Ind Ltd Cut wire for electric discharge machining
US4734300A (en) * 1986-03-14 1988-03-29 Hughes Aircraft Company Methods for removing parylene coatings from predetermined, desired areas of a substrate
US4819618A (en) * 1986-08-18 1989-04-11 Liprie Sam F Iridium/platinum implant, method of encapsulation, and method of implantation
US5041041A (en) * 1986-12-22 1991-08-20 Gte Products Corporation Method of fabricating a composite lamp filament
US4917965A (en) * 1987-08-25 1990-04-17 National Research Institute For Metals Multifilament Nb3 Al superconducting linear composite articles
US5045527A (en) * 1987-10-02 1991-09-03 Fujikura Ltd. Method of producing a superconductive oxide conductor
US4889107A (en) * 1988-02-10 1989-12-26 Kaufman Jack W Surgical retractor
US5366504A (en) * 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5360440A (en) * 1992-03-09 1994-11-01 Boston Scientific Corporation In situ apparatus for generating an electrical current in a biological environment
JPH07505316A (en) * 1992-03-31 1995-06-15 ボストン サイエンティフィック コーポレーション medical wire
CA2152594C (en) * 1993-01-19 1998-12-01 David W. Mayer Clad composite stent
US5630840A (en) * 1993-01-19 1997-05-20 Schneider (Usa) Inc Clad composite stent
US5441516A (en) * 1994-03-03 1995-08-15 Scimed Lifesystems Inc. Temporary stent
US5554181A (en) * 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
US6451047B2 (en) * 1995-03-10 2002-09-17 Impra, Inc. Encapsulated intraluminal stent-graft and methods of making same
US6027528A (en) * 1996-05-28 2000-02-22 Cordis Corporation Composite material endoprosthesis
JPH1066730A (en) 1996-08-28 1998-03-10 Sumitomo Bakelite Co Ltd Luminal stent and its manufacture
DE19703482A1 (en) * 1997-01-31 1998-08-06 Ernst Peter Prof Dr M Strecker Stent
US5830229A (en) * 1997-03-07 1998-11-03 Micro Therapeutics Inc. Hoop stent
US8172897B2 (en) * 1997-04-15 2012-05-08 Advanced Cardiovascular Systems, Inc. Polymer and metal composite implantable medical devices
US6086611A (en) * 1997-09-25 2000-07-11 Ave Connaught Bifurcated stent
US6241691B1 (en) * 1997-12-05 2001-06-05 Micrus Corporation Coated superelastic stent
US6165194A (en) * 1998-07-24 2000-12-26 Micrus Corporation Intravascular flow modifier and reinforcement device
US6287333B1 (en) * 1999-03-15 2001-09-11 Angiodynamics, Inc. Flexible stent
US6475235B1 (en) * 1999-11-16 2002-11-05 Iowa-India Investments Company, Limited Encapsulated stent preform
GB0003387D0 (en) * 2000-02-14 2000-04-05 Angiomed Ag Stent matrix
US6652574B1 (en) * 2000-09-28 2003-11-25 Vascular Concepts Holdings Limited Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer
US6926733B2 (en) * 2001-08-02 2005-08-09 Boston Scientific Scimed, Inc. Method for enhancing sheet or tubing metal stent radiopacity
US7179283B2 (en) * 2001-11-02 2007-02-20 Scimed Life Systems, Inc. Vapor deposition process for producing a stent-graft and a stent-graft produced therefrom
JP2005514155A (en) * 2001-12-29 2005-05-19 グローバル メディカル サイエンシズ リミテッド Stent and manufacturing method thereof (deformation)
US20040068189A1 (en) * 2002-02-28 2004-04-08 Wilson Richard R. Ultrasound catheter with embedded conductors
US20040051441A1 (en) * 2002-07-09 2004-03-18 Paul Leblans Binderless storage phosphor screen comprising a support including an amorphous (a-C) carbon layer
US20040143317A1 (en) 2003-01-17 2004-07-22 Stinson Jonathan S. Medical devices
DE10335649A1 (en) * 2003-07-30 2005-02-24 Jotec Gmbh Braid stent for implantation in a blood vessel
US7193226B2 (en) * 2003-09-30 2007-03-20 Agfa-Gevaert Scratch resistant moisture-protecting parylene layers
US9078780B2 (en) * 2003-11-08 2015-07-14 Cook Medical Technologies Llc Balloon flareable branch vessel prosthesis and method
US7329279B2 (en) * 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20080147111A1 (en) * 2005-01-03 2008-06-19 Eric Johnson Endoluminal Filter With Fixation
US20070021685A1 (en) * 2005-05-04 2007-01-25 Abbott Laboratories Abbott Vascular Devices Guidewire apparatus with an expandable portion and methods of use
EP2666508B1 (en) * 2005-05-13 2019-07-24 Boston Scientific Limited Integrated stent repositioning and retrieval loop

Patent Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101392B2 (en) * 1992-03-31 2006-09-05 Boston Scientific Corporation Tubular medical endoprostheses
US5685933A (en) * 1993-04-26 1997-11-11 Toyota Jidosha Kabushiki Kaisha Method of manufacturing a drive shaft
US5858556A (en) * 1997-01-21 1999-01-12 Uti Corporation Multilayer composite tubular structure and method of making
US6217609B1 (en) * 1998-06-30 2001-04-17 Schneider (Usa) Inc Implantable endoprosthesis with patterned terminated ends and methods for making same
US7678217B2 (en) * 2001-12-20 2010-03-16 Trivascular2, Inc. Method for manufacturing an endovascular graft section
US7125464B2 (en) * 2001-12-20 2006-10-24 Boston Scientific Santa Rosa Corp. Method for manufacturing an endovascular graft section
US8372134B2 (en) * 2002-05-11 2013-02-12 Boston Scientific Scimed, Inc. Stent
US20050182481A1 (en) * 2002-05-11 2005-08-18 Tilman Schlick Stent
US20030212450A1 (en) * 2002-05-11 2003-11-13 Tilman Schlick Stent
US7731742B2 (en) * 2002-05-11 2010-06-08 Boston Scientific Scimed, Inc. Stent
US20110276122A1 (en) * 2002-05-11 2011-11-10 Boston Scientific Scimed, Inc. Stent
US20050283962A1 (en) * 2002-11-20 2005-12-29 Younes Boudjemline Method for making a medical implant with open-work structure and implant obtained by said method
WO2004047681A1 (en) * 2002-11-20 2004-06-10 Younes Boudjemline Method for making a medical implant with open-work structure and implant obtained by said method
US8052744B2 (en) * 2006-09-15 2011-11-08 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US8597344B2 (en) * 2008-01-07 2013-12-03 DePuy Synthes Products, LLC Radiopaque super-elastic intravascular stent
US20100152837A1 (en) * 2008-01-07 2010-06-17 Micrus Endovascular Corporation Radiopaque super-elastic intravascular stent
US20140058500A1 (en) * 2008-01-07 2014-02-27 DePuy Synthes Products, LLC Radiopaque super-elastic intravascular stent
US8623071B2 (en) * 2008-01-07 2014-01-07 DePuy Synthes Products, LLC Radiopaque super-elastic intravascular stent
US20090177268A1 (en) * 2008-01-07 2009-07-09 Micrus Endovascular Corporation Radiopaque super-elastic intravascular stent
US20120186420A1 (en) * 2009-01-26 2012-07-26 Boston Scientific Scimed, Inc. Atraumatic Stent and Method and Apparatus for making the same
US20130269506A1 (en) * 2009-01-26 2013-10-17 Boston Scientific Scimed, Inc. Atraumatic Stent and Method and Apparatus for making the same
US8459164B2 (en) * 2009-01-26 2013-06-11 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
US20100191319A1 (en) * 2009-01-26 2010-07-29 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
US8151682B2 (en) * 2009-01-26 2012-04-10 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
US8677874B2 (en) * 2009-01-26 2014-03-25 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
US20140088688A1 (en) * 2009-01-26 2014-03-27 Boston Scientific Scimed, Inc. Atraumatic Stent and Method and Apparatus for making the same
US20130289704A1 (en) * 2012-04-26 2013-10-31 Medtronic Vascular, Inc. Radiopaque Enhanced Cobalt Alloy for Stents
US20130289705A1 (en) * 2012-04-26 2013-10-31 Medtronic Vascular, Inc. Radiopaque Enhanced Nickel Alloy for Stents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
English machine translation of JP 10-66730. *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
DE102015107291B4 (en) * 2014-05-28 2017-06-08 Acandis Gmbh & Co. Kg stent
US10806560B2 (en) 2015-05-18 2020-10-20 Pulmair Medical, Inc. Implantable artificial bronchus and use of an implantable artificial bronchus
US11096773B2 (en) 2015-05-18 2021-08-24 Pulmair Medical, Inc. Implantable artificial bronchus and use of an implantable artificial bronchus
USD902407S1 (en) 2019-11-19 2020-11-17 Pulmair Medical, Inc. Implantable artificial bronchus
USD954953S1 (en) 2020-11-03 2022-06-14 Pulmair Medical, Inc. Implantable artificial bronchus
USD1014758S1 (en) 2023-04-19 2024-02-13 Pulmair Medical, Inc. Implantable artificial bronchus

Also Published As

Publication number Publication date
CN101969891B (en) 2014-10-29
US8623071B2 (en) 2014-01-07
CN101969891A (en) 2011-02-09
WO2009089218A3 (en) 2009-10-29
US8597344B2 (en) 2013-12-03
CA2711484A1 (en) 2009-07-16
CA2951303A1 (en) 2009-07-16
WO2009089216A3 (en) 2009-10-29
US20100152837A1 (en) 2010-06-17
JP5419893B2 (en) 2014-02-19
US20140058500A1 (en) 2014-02-27
WO2009089216A2 (en) 2009-07-16
WO2009089218A2 (en) 2009-07-16
JP2011509124A (en) 2011-03-24
CA2711484C (en) 2017-01-24
US20090177268A1 (en) 2009-07-09
ES2585404T3 (en) 2016-10-05
EP2247268B1 (en) 2016-05-18
EP2247268A2 (en) 2010-11-10

Similar Documents

Publication Publication Date Title
US8623071B2 (en) Radiopaque super-elastic intravascular stent
US11291458B2 (en) Vaso-occlusive device and delivery assembly
AU2018253740B2 (en) Braid expansion ring with markers
US20050079196A1 (en) Medical implant
JP2003524433A (en) Quickly detachable electrically insulated implant
JP2008515467A (en) Vascular occlusion device with embolic mesh ribbon
JP2002523125A (en) Vaso-occlusive coil
WO2007126931A2 (en) Embolic protection devices having radiopaque markers
WO2023154757A1 (en) Vaso-occlusive device and delivery assembly
WO2019026363A1 (en) In vivo indwelling instrument and in vivo indwelling instrument delivery system
JP2005152586A (en) Blood vessel occlusion device and inserting device therefor

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION